Arcus Biosciences COO Jennifer Jarrett to Resign Effective March 30, 2024
Published on 3/23/2026

AI Summary
Jennifer Jarrett, the Chief Operating Officer of Arcus Biosciences, announced her resignation, effective March 30, 2024. This development is notable as it could impact the company's operational strategy and direction. It remains to be seen how this change will influence investor sentiment and stock performance in the upcoming months. Arcus Biosciences has not provided specific details regarding interim leadership or the succession plan.
Related News

Earnings
Micron (MU) Expects 268% Revenue Growth by June 24 Earnings Report
Jun 21

Earnings
PFE and JNJ Annual Dividend Income of $3,540 for Investors
Jun 21

Earnings
Absci Corporation (ABSI) Shares Trade at $7.27 Amid AI Drug Development
Jun 21

Earnings
KNTK Dividend Stock Offers 7% Yield Amid Fed Rate Hike Hints
Jun 21